TRICARE West Expands NeuroStar TMS Coverage To Include Adolescents Aged 15+ Struggling With Depression

Neuronetics, Inc., a medical technology company that designed and markets NeuroStar Advanced Therapy, announced that TriWest, the regional administrator for TRICARE, has updated its medical policy to include transcranial magnetic stimulation (TMS) coverage for adolescents aged 15 and older diagnosed with major depressive disorder (MDD). TRICARE coverage is primarily used by active and retired military service members and their eligible family members.

The NeuroStar Advanced Therapy System is cleared by the U.S. Food and Drug Administration (FDA) for adults with MDD, as an adjunct for adults with obsessive-compulsive disorder, to decrease anxiety symptoms in adults with MDD that . . .